top of page

The CEO of Marengo Therapeutics talks about his company's focus on activating and expanding T-cells

Zhen Su gives an overview Marengo, shares his view of #SITC23, and describes SITC's new biotech initiative with its goal of 100 new approved medicines over the next decade.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

bp-logo.png

Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world. 

bottom of page